Empowered Funds LLC Purchases 14,829 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Empowered Funds LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 181.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,006 shares of the medical equipment provider’s stock after purchasing an additional 14,829 shares during the quarter. Empowered Funds LLC’s holdings in Intuitive Surgical were worth $12,008,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of ISRG. Forbes J M & Co. LLP increased its position in Intuitive Surgical by 211.5% during the fourth quarter. Forbes J M & Co. LLP now owns 1,953 shares of the medical equipment provider’s stock worth $1,019,000 after acquiring an additional 1,326 shares during the period. Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 1.6% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 564,332 shares of the medical equipment provider’s stock worth $294,559,000 after acquiring an additional 8,671 shares during the period. Kingsview Wealth Management LLC increased its position in Intuitive Surgical by 2.2% during the fourth quarter. Kingsview Wealth Management LLC now owns 4,354 shares of the medical equipment provider’s stock worth $2,273,000 after acquiring an additional 94 shares during the period. TFG Advisers LLC increased its position in Intuitive Surgical by 9.0% during the fourth quarter. TFG Advisers LLC now owns 821 shares of the medical equipment provider’s stock worth $429,000 after acquiring an additional 68 shares during the period. Finally, Vest Financial LLC increased its position in Intuitive Surgical by 22.1% during the fourth quarter. Vest Financial LLC now owns 2,725 shares of the medical equipment provider’s stock worth $1,422,000 after acquiring an additional 493 shares during the period. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. Bernstein Bank boosted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Down 0.9 %

Intuitive Surgical stock opened at $582.98 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $207.65 billion, a PE ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. The company’s 50-day moving average is $554.85 and its two-hundred day moving average is $513.96.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,940 shares of company stock worth $3,333,485. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.